While the loss of GRHL2 is implicated in increased migratory behavior commonly associated with metastasis in ER-positive breast cancer cells, high levels of GRHL2 expression often occur in ER-positive breast cancer cells and are associated with poor overall and distant metastasis-free survival in breast cancer patients [7,16,26]. The gene discussed is GRHL2; the disease is breast cancer.